|
Spiriva Respimat Now Approved for Asthma
Pharmacy Times The FDA has added an asthma indication to Boehringer Ingelheim's tiotropium bromide inhalation spray (Spiriva Respimat). This long-acting muscarinic antagonist (LAMA) was originally approved in September 2014 for the maintenance treatment of chronic … FDA approves Spiriva Respimat for asthma in adults, adolescents |
View full post on asthma – Google News